← Leaderboards
Allen A Mitchell
Boston University Medical Campus
$16,276,468
Attributed
$26,734,589
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
CDC$12,974,400 · 3
NIH$11,294,635 · 5
AHRQ$2,465,554 · 1
By mechanism
U01$12,974,400 · 3
R01$11,294,635 · 4
R18$2,465,554 · 1
N01$0 · 1
Top collaborators
- Marlene Anderka9 shared
- Sonia Hernandez-Diaz9 shared
- Lewis B. Holmes8 shared
- Mahsa M Yazdy6 shared
- Martha M Werler2 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Martha M Werler$16,918,085
Others in their field
Top investigators on “Interview”
- David R. Weir · University Of Michigan At Ann Arbor$402,025,081
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$92,110,019
- Linda J Waite · University Of Chicago$88,691,160
- Robert J Willis · University Of Michigan At Ann Arbor$71,166,480
- Arie Kapteyn · Rand Corporation$66,087,233
- Narayan Sastry · University Of Michigan At Ann Arbor$62,231,924
Research focus
InterviewOdds RatioMalformationMetropolitanNorth AmericaNursesMedicalGenitourinary SystemIbuprofenHuman SubjectCase ControlMothersCongenital AbnormalityConfidence IntervalsHospitalsInfantDefectGeneral PopulationEpidemiologyBirthDrug UsageEmbryo /Fetus Drug Adverse EffectAreaPharmaceutical Preparations
Grant awards (42)
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposures) - Core (Component A) & Steps Stillbirth (Component B)$1,050,000
U01 · FY2022 · DD
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposures) - Core (Component A) & Steps Stillbirth (Component B)$1,150,000
U01 · FY2021 · DD
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposures) - Core (Component A) & Steps Stillbirth (Component B)$1,150,000
U01 · FY2020 · DD
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core$1,119,000
U01 · FY2019 · DD
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core$995,000
U01 · FY2018 · DD
BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core$995,000
U01 · FY2018 · DD
Massachusetts Center for Birth Defects Research and Prevention$800,000
U01 · FY2015 · DD
Massachusetts Stillbirth Risk Factor Pilot Project$250,000
U01 · FY2015 · DD
Massachusetts Center for Birth Defects Research and Prevention$765,000
U01 · FY2014 · DD
Massachusetts Center for Birth Defects Research and Prevention$580,400
U01 · FY2013 · DD
Specific birth defects and asthma medications in pregnancy: Demonstration project$488,894
R18 · FY2013 · HS · contact PI
Massachusetts Center for Birth Defects Research and Prevention$350,000
U01 · FY2013 · DD
Massachusetts Center for Birth Defects Research and Prevention$870,000
U01 · FY2012 · DD
Phthalates in Drugs and Male Genital Malformation$648,116
R01 · FY2012 · HD
Specific birth defects and asthma medications in pregnancy: Demonstration project$490,991
R18 · FY2012 · HS · contact PI
Massachusetts Center for Birth Defects Research and Prevention$900,000
U01 · FY2011 · DD
Phthalates in Drugs and Male Genital Malformation$647,384
R01 · FY2011 · HD
Specific birth defects and asthma medications in pregnancy: Demonstration project$491,536
R18 · FY2011 · HS · contact PI
Teratogenicity of drugs commonly used in pregnancy$405,376
R01 · FY2011 · HD · contact PI
Massachusetts Center for Birth Defects Research and Prevention$1,000,000
U01 · FY2010 · DD
Teratogenicity of drugs commonly used in pregnancy$928,060
R01 · FY2010 · HD · contact PI
Phthalates in Drugs and Male Genital Malformation$657,654
R01 · FY2010 · HD
Teratogenicity of drugs commonly used in pregnancy$571,940
R01 · FY2010 · HD · contact PI
Specific birth defects and asthma medications in pregnancy: Demonstration project$498,362
R18 · FY2010 · HS · contact PI
Teratogenicity of drugs commonly used in pregnancy$411,227
R01 · FY2010 · HD · contact PI
Massachusetts Center for Birth Defects Research and Prevention$1,000,000
U01 · FY2009 · DD
Phthalates in Drugs and Male Genital Malformation$521,040
R01 · FY2009 · HD
Specific birth defects and asthma medications in pregnancy: Demonstration project$495,771
R18 · FY2009 · HS · contact PI
Teratogenicity of drugs commonly used in pregnancy$399,246
R01 · FY2009 · HD · contact PI
Teratogenicity of Drugs Most Commonly Used in Pregnancy$264,692
R01 · FY2007 · HD · contact PI
Teratogenicity of Drugs Most Commonly Used in Pregnancy$272,621
R01 · FY2006 · HD · contact PI
Teratogenicity of Drugs Most Commonly Used in Pregnancy$279,306
R01 · FY2005 · HD
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$730,065
R01 · FY2004 · ES
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$42,532
R01 · FY2004 · ES
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$708,857
R01 · FY2003 · ES
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$725,811
R01 · FY2002 · ES
RISK FACTORS FOR PULMONARY HYPERTENSION OF THE NEWBORN$538,108
R01 · FY2002 · HL
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$705,769
R01 · FY2001 · ES
RISK FACTORS FOR PULMONARY HYPERTENSION OF THE NEWBORN$575,363
R01 · FY2001 · HL
PHARMACOGENETIC DETERMINANTS OF HUMAN BIRTH DEFECTS$702,204
R01 · FY2000 · ES
RISK FACTORS FOR PULMONARY HYPERTENSION OF THE NEWBORN$559,264
R01 · FY2000 · HL
INFANT SLEEP POSITION AND SIDS RISK$0
N01 · FY2000 · HD